key: cord-0763632-h93ho3jj
authors: Akşit, Ercan; Çil, Özge Çağlar; Kaya, Hakkı
title: Olfactory Dysfunction May Predict Myocardial Injury in COVID-19 Patients
date: 2020-09-02
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.110232
sha: ce10bb14cda03e62c13ff49009e2e3aeb11e5fc9
doc_id: 763632
cord_uid: h93ho3jj

nan

As a hypothesis, in the coronavirus disease 2019 (COVID-19) pandemic, growing evidence suggests a possible correlation between increased cytokine levels, olfactory dysfunction and myocardial injury. Puntmann [2] . In their autopsy study, Solomon et al. reported that there was no damage to olfactory bulbs or tracts of COVID-19 patients [3] whereas Torabi and al. reported significant increase in local tumour necrosis factor alpha (TNF-α) levels of the olfactory epithelium in COVID-19 patients [4] . Based on this, it has been observed that covid-19 disease has more frequent occurrence of sudden olfactory dysfunction than other flu diseases, cardiac involvement and thrombogenic events are more frequent, and it is a 'cytokine storm' since the first symptom phase. In addition we showed a direct relationship between the severity of heart failure and that of olfactory dysfunction. An important hypothesis explaining this clinical relationship is that TNF-α and interleukin-1 (IL-1) levels increase in heart failure patients and in those with olfactory dysfunction [5] . Considering this literature and two important recent studies, the similarity between the frequency of cardiac involvement (78%) and that of sudden smell loss (64.7%) in COVID-19 patients suggests that olfactory dysfunction in COVID-19 patients can be a predictor of myocardial injury. When olfactory dysfunction is detected in COVID-19 patients, providing optimal primary and secondary cardiovascular prevention can positively contribute to the disease course.

Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)

Predictive value of sudden olfactory loss in the diagnosis of COVID-19

Neuropathological features of Covid-19

Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia

Olfactory dysfunction in patients with ischemic heart failure